Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Acinetobacter Infections Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.
LPI (LP Information)' newest research report, the “Acinetobacter Infections Treatment Industry Forecast” looks at past sales and reviews total world Acinetobacter Infections Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Acinetobacter Infections Treatment sales for 2025 through 2031. With Acinetobacter Infections Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acinetobacter Infections Treatment industry.
This Insight Report provides a comprehensive analysis of the global Acinetobacter Infections Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acinetobacter Infections Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acinetobacter Infections Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acinetobacter Infections Treatment and breaks down the forecast by Type, by Pipeline, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acinetobacter Infections Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Acinetobacter Infections Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Acinetobacter Infections Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.
LPI (LP Information)' newest research report, the “Acinetobacter Infections Treatment Industry Forecast” looks at past sales and reviews total world Acinetobacter Infections Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Acinetobacter Infections Treatment sales for 2025 through 2031. With Acinetobacter Infections Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acinetobacter Infections Treatment industry.
This Insight Report provides a comprehensive analysis of the global Acinetobacter Infections Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acinetobacter Infections Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acinetobacter Infections Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acinetobacter Infections Treatment and breaks down the forecast by Type, by Pipeline, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acinetobacter Infections Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Acinetobacter Infections Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Sulbactam
- Carbapenems
- Aminoglycosides
- Polymyxins
- Tetracyclines
- Others
- ETX2514
- Nacubactam RG6080
- Arenicin
- VXD-001
- Small Molecule Antibiotic
- AR-401 mAB
- LCB01-0371 (PO)
- GN-4474
- Antibacterial Antibody
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Entasis Therapeutics
- Roche
- Adenium Biotech
- Vaxdyn
- Hsiri Therapeutics
- Aridis Pharmaceuticals
- LegoChem Biosciences
- Atterx Biotherapeutics
- Achaogen
- Peptilogics
- Sealife PHARMA
- Shionogi
- Techulon
- Tetraphase Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acinetobacter Infections Treatment Market Size (2020-2031)
2.1.2 Acinetobacter Infections Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Acinetobacter Infections Treatment by Country/Region (2020, 2024 & 2031)
2.2 Acinetobacter Infections Treatment Segment by Type
2.2.1 Sulbactam
2.2.2 Carbapenems
2.2.3 Aminoglycosides
2.2.4 Polymyxins
2.2.5 Tetracyclines
2.2.6 Others
2.3 Acinetobacter Infections Treatment Market Size by Type
2.3.1 Acinetobacter Infections Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Acinetobacter Infections Treatment Market Size Market Share by Type (2020-2025)
2.4 Acinetobacter Infections Treatment Segment by Pipeline
2.4.1 ETX2514
2.4.2 Nacubactam RG6080
2.4.3 Arenicin
2.4.4 VXD-001
2.4.5 Small Molecule Antibiotic
2.4.6 AR-401 mAB
2.4.7 LCB01-0371 (PO)
2.4.8 GN-4474
2.4.9 Antibacterial Antibody
2.5 Acinetobacter Infections Treatment Market Size by Pipeline
2.5.1 Acinetobacter Infections Treatment Market Size CAGR by Pipeline (2020 VS 2024 VS 2031)
2.5.2 Global Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2020-2025)
3 ACINETOBACTER INFECTIONS TREATMENT MARKET SIZE BY PLAYER
3.1 Acinetobacter Infections Treatment Market Size Market Share by Player
3.1.1 Global Acinetobacter Infections Treatment Revenue by Player (2020-2025)
3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Acinetobacter Infections Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACINETOBACTER INFECTIONS TREATMENT BY REGION
4.1 Acinetobacter Infections Treatment Market Size by Region (2020-2025)
4.2 Global Acinetobacter Infections Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acinetobacter Infections Treatment Market Size Growth (2020-2025)
4.4 APAC Acinetobacter Infections Treatment Market Size Growth (2020-2025)
4.5 Europe Acinetobacter Infections Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Acinetobacter Infections Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Acinetobacter Infections Treatment Market Size by Country (2020-2025)
5.2 Americas Acinetobacter Infections Treatment Market Size by Type (2020-2025)
5.3 Americas Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acinetobacter Infections Treatment Market Size by Region (2020-2025)
6.2 APAC Acinetobacter Infections Treatment Market Size by Type (2020-2025)
6.3 APAC Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acinetobacter Infections Treatment Market Size by Country (2020-2025)
7.2 Europe Acinetobacter Infections Treatment Market Size by Type (2020-2025)
7.3 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acinetobacter Infections Treatment by Region (2020-2025)
8.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACINETOBACTER INFECTIONS TREATMENT MARKET FORECAST
10.1 Global Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.1.1 Global Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.1.2 Americas Acinetobacter Infections Treatment Forecast
10.1.3 APAC Acinetobacter Infections Treatment Forecast
10.1.4 Europe Acinetobacter Infections Treatment Forecast
10.1.5 Middle East & Africa Acinetobacter Infections Treatment Forecast
10.2 Americas Acinetobacter Infections Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Acinetobacter Infections Treatment Forecast
10.2.2 Canada Market Acinetobacter Infections Treatment Forecast
10.2.3 Mexico Market Acinetobacter Infections Treatment Forecast
10.2.4 Brazil Market Acinetobacter Infections Treatment Forecast
10.3 APAC Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.3.1 China Acinetobacter Infections Treatment Market Forecast
10.3.2 Japan Market Acinetobacter Infections Treatment Forecast
10.3.3 Korea Market Acinetobacter Infections Treatment Forecast
10.3.4 Southeast Asia Market Acinetobacter Infections Treatment Forecast
10.3.5 India Market Acinetobacter Infections Treatment Forecast
10.3.6 Australia Market Acinetobacter Infections Treatment Forecast
10.4 Europe Acinetobacter Infections Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Acinetobacter Infections Treatment Forecast
10.4.2 France Market Acinetobacter Infections Treatment Forecast
10.4.3 UK Market Acinetobacter Infections Treatment Forecast
10.4.4 Italy Market Acinetobacter Infections Treatment Forecast
10.4.5 Russia Market Acinetobacter Infections Treatment Forecast
10.5 Middle East & Africa Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Acinetobacter Infections Treatment Forecast
10.5.2 South Africa Market Acinetobacter Infections Treatment Forecast
10.5.3 Israel Market Acinetobacter Infections Treatment Forecast
10.5.4 Turkey Market Acinetobacter Infections Treatment Forecast
10.6 Global Acinetobacter Infections Treatment Forecast by Type (2026-2031)
10.7 Global Acinetobacter Infections Treatment Forecast by Pipeline (2026-2031)
10.7.1 GCC Countries Market Acinetobacter Infections Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Entasis Therapeutics
11.1.1 Entasis Therapeutics Company Information
11.1.2 Entasis Therapeutics Acinetobacter Infections Treatment Product Offered
11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Entasis Therapeutics Main Business Overview
11.1.5 Entasis Therapeutics Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Acinetobacter Infections Treatment Product Offered
11.2.3 Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Adenium Biotech
11.3.1 Adenium Biotech Company Information
11.3.2 Adenium Biotech Acinetobacter Infections Treatment Product Offered
11.3.3 Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Adenium Biotech Main Business Overview
11.3.5 Adenium Biotech Latest Developments
11.4 Vaxdyn
11.4.1 Vaxdyn Company Information
11.4.2 Vaxdyn Acinetobacter Infections Treatment Product Offered
11.4.3 Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Vaxdyn Main Business Overview
11.4.5 Vaxdyn Latest Developments
11.5 Hsiri Therapeutics
11.5.1 Hsiri Therapeutics Company Information
11.5.2 Hsiri Therapeutics Acinetobacter Infections Treatment Product Offered
11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Hsiri Therapeutics Main Business Overview
11.5.5 Hsiri Therapeutics Latest Developments
11.6 Aridis Pharmaceuticals
11.6.1 Aridis Pharmaceuticals Company Information
11.6.2 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Offered
11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Aridis Pharmaceuticals Main Business Overview
11.6.5 Aridis Pharmaceuticals Latest Developments
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Company Information
11.7.2 LegoChem Biosciences Acinetobacter Infections Treatment Product Offered
11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 LegoChem Biosciences Main Business Overview
11.7.5 LegoChem Biosciences Latest Developments
11.8 Atterx Biotherapeutics
11.8.1 Atterx Biotherapeutics Company Information
11.8.2 Atterx Biotherapeutics Acinetobacter Infections Treatment Product Offered
11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Atterx Biotherapeutics Main Business Overview
11.8.5 Atterx Biotherapeutics Latest Developments
11.9 Achaogen
11.9.1 Achaogen Company Information
11.9.2 Achaogen Acinetobacter Infections Treatment Product Offered
11.9.3 Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Achaogen Main Business Overview
11.9.5 Achaogen Latest Developments
11.10 Peptilogics
11.10.1 Peptilogics Company Information
11.10.2 Peptilogics Acinetobacter Infections Treatment Product Offered
11.10.3 Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Peptilogics Main Business Overview
11.10.5 Peptilogics Latest Developments
11.11 Sealife PHARMA
11.11.1 Sealife PHARMA Company Information
11.11.2 Sealife PHARMA Acinetobacter Infections Treatment Product Offered
11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sealife PHARMA Main Business Overview
11.11.5 Sealife PHARMA Latest Developments
11.12 Shionogi
11.12.1 Shionogi Company Information
11.12.2 Shionogi Acinetobacter Infections Treatment Product Offered
11.12.3 Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Shionogi Main Business Overview
11.12.5 Shionogi Latest Developments
11.13 Techulon
11.13.1 Techulon Company Information
11.13.2 Techulon Acinetobacter Infections Treatment Product Offered
11.13.3 Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Techulon Main Business Overview
11.13.5 Techulon Latest Developments
11.14 Tetraphase Pharmaceuticals
11.14.1 Tetraphase Pharmaceuticals Company Information
11.14.2 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Offered
11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Tetraphase Pharmaceuticals Main Business Overview
11.14.5 Tetraphase Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Acinetobacter InfectionsTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Acinetobacter InfectionsTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sulbactam
Table 4. Major Players of Carbapenems
Table 5. Major Players of Aminoglycosides
Table 6. Major Players of Polymyxins
Table 7. Major Players ofTetracyclines
Table 8. Major Players of Others
Table 9. Acinetobacter InfectionsTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 11. Global Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Table 12. Acinetobacter InfectionsTreatment Market Size CAGR by Pipeline (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 14. Global Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Table 15. Global Acinetobacter InfectionsTreatment Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Acinetobacter InfectionsTreatment Revenue Market Share by Player (2020-2025)
Table 17. Acinetobacter InfectionsTreatment Key Players Head office and Products Offered
Table 18. Acinetobacter InfectionsTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Acinetobacter InfectionsTreatment Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Table 23. Global Acinetobacter InfectionsTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Acinetobacter InfectionsTreatment Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Acinetobacter InfectionsTreatment Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Acinetobacter InfectionsTreatment Market Size Market Share by Country (2020-2025)
Table 27. Americas Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 28. Americas Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Table 29. Americas Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 30. Americas Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Table 31. APAC Acinetobacter InfectionsTreatment Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Table 33. APAC Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 34. APAC Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 35. Europe Acinetobacter InfectionsTreatment Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Acinetobacter InfectionsTreatment Market Size Market Share by Country (2020-2025)
Table 37. Europe Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 38. Europe Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 39. Middle East & Africa Acinetobacter InfectionsTreatment Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 41. Middle East & Africa Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Acinetobacter InfectionsTreatment
Table 43. Key Market Challenges & Risks of Acinetobacter InfectionsTreatment
Table 44. Key IndustryTrends of Acinetobacter InfectionsTreatment
Table 45. Global Acinetobacter InfectionsTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 46. Global Acinetobacter InfectionsTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 47. Global Acinetobacter InfectionsTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 48. Global Acinetobacter InfectionsTreatment Market SizeForecast by Pipeline (2026-2031) & ($ millions)
Table 49. EntasisTherapeutics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 50. EntasisTherapeutics Acinetobacter InfectionsTreatment Product Offered
Table 51. EntasisTherapeutics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. EntasisTherapeutics Main Business
Table 53. EntasisTherapeutics Latest Developments
Table 54. Roche Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 55. Roche Acinetobacter InfectionsTreatment Product Offered
Table 56. Roche Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Adenium Biotech Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 60. Adenium Biotech Acinetobacter InfectionsTreatment Product Offered
Table 61. Adenium Biotech Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Adenium Biotech Main Business
Table 63. Adenium Biotech Latest Developments
Table 64. Vaxdyn Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 65. Vaxdyn Acinetobacter InfectionsTreatment Product Offered
Table 66. Vaxdyn Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Vaxdyn Main Business
Table 68. Vaxdyn Latest Developments
Table 69. HsiriTherapeutics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 70. HsiriTherapeutics Acinetobacter InfectionsTreatment Product Offered
Table 71. HsiriTherapeutics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. HsiriTherapeutics Main Business
Table 73. HsiriTherapeutics Latest Developments
Table 74. Aridis Pharmaceuticals Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 75. Aridis Pharmaceuticals Acinetobacter InfectionsTreatment Product Offered
Table 76. Aridis Pharmaceuticals Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Aridis Pharmaceuticals Main Business
Table 78. Aridis Pharmaceuticals Latest Developments
Table 79. LegoChem Biosciences Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 80. LegoChem Biosciences Acinetobacter InfectionsTreatment Product Offered
Table 81. LegoChem Biosciences Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. LegoChem Biosciences Main Business
Table 83. LegoChem Biosciences Latest Developments
Table 84. Atterx Biotherapeutics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 85. Atterx Biotherapeutics Acinetobacter InfectionsTreatment Product Offered
Table 86. Atterx Biotherapeutics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Atterx Biotherapeutics Main Business
Table 88. Atterx Biotherapeutics Latest Developments
Table 89. Achaogen Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 90. Achaogen Acinetobacter InfectionsTreatment Product Offered
Table 91. Achaogen Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Achaogen Main Business
Table 93. Achaogen Latest Developments
Table 94. Peptilogics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 95. Peptilogics Acinetobacter InfectionsTreatment Product Offered
Table 96. Peptilogics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Peptilogics Main Business
Table 98. Peptilogics Latest Developments
Table 99. Sealife PHARMA Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 100. Sealife PHARMA Acinetobacter InfectionsTreatment Product Offered
Table 101. Sealife PHARMA Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Sealife PHARMA Main Business
Table 103. Sealife PHARMA Latest Developments
Table 104. Shionogi Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 105. Shionogi Acinetobacter InfectionsTreatment Product Offered
Table 106. Shionogi Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Shionogi Main Business
Table 108. Shionogi Latest Developments
Table 109.Techulon Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 110.Techulon Acinetobacter InfectionsTreatment Product Offered
Table 111.Techulon Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112.Techulon Main Business
Table 113.Techulon Latest Developments
Table 114.Tetraphase Pharmaceuticals Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 115.Tetraphase Pharmaceuticals Acinetobacter InfectionsTreatment Product Offered
Table 116.Tetraphase Pharmaceuticals Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117.Tetraphase Pharmaceuticals Main Business
Table 118.Tetraphase Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Acinetobacter InfectionsTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acinetobacter InfectionsTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Acinetobacter InfectionsTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Acinetobacter InfectionsTreatment Sales Market Share by Country/Region (2024)
Figure 8. Acinetobacter InfectionsTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Acinetobacter InfectionsTreatment Market Size Market Share byType in 2024
Figure 10. Acinetobacter InfectionsTreatment in ETX2514
Figure 11. Global Acinetobacter InfectionsTreatment Market: ETX2514 (2020-2025) & ($ millions)
Figure 12. Acinetobacter InfectionsTreatment in Nacubactam RG6080
Figure 13. Global Acinetobacter InfectionsTreatment Market: Nacubactam RG6080 (2020-2025) & ($ millions)
Figure 14. Acinetobacter InfectionsTreatment in Arenicin
Figure 15. Global Acinetobacter InfectionsTreatment Market: Arenicin (2020-2025) & ($ millions)
Figure 16. Acinetobacter InfectionsTreatment in VXD-001
Figure 17. Global Acinetobacter InfectionsTreatment Market: VXD-001 (2020-2025) & ($ millions)
Figure 18. Acinetobacter InfectionsTreatment in Small Molecule Antibiotic
Figure 19. Global Acinetobacter InfectionsTreatment Market: Small Molecule Antibiotic (2020-2025) & ($ millions)
Figure 20. Acinetobacter InfectionsTreatment in AR-401 mAB
Figure 21. Global Acinetobacter InfectionsTreatment Market: AR-401 mAB (2020-2025) & ($ millions)
Figure 22. Acinetobacter InfectionsTreatment in LCB01-0371 (PO)
Figure 23. Global Acinetobacter InfectionsTreatment Market: LCB01-0371 (PO) (2020-2025) & ($ millions)
Figure 24. Acinetobacter InfectionsTreatment in GN-4474
Figure 25. Global Acinetobacter InfectionsTreatment Market: GN-4474 (2020-2025) & ($ millions)
Figure 26. Acinetobacter InfectionsTreatment in Antibacterial Antibody
Figure 27. Global Acinetobacter InfectionsTreatment Market: Antibacterial Antibody (2020-2025) & ($ millions)
Figure 28. Global Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline in 2024
Figure 29. Global Acinetobacter InfectionsTreatment Revenue Market Share by Player in 2024
Figure 30. Global Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Figure 31. Americas Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 32. APAC Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 33. Europe Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 34. Middle East & Africa Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 35. Americas Acinetobacter InfectionsTreatment Value Market Share by Country in 2024
Figure 36. United States Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Canada Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Mexico Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 39. Brazil Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 40. APAC Acinetobacter InfectionsTreatment Market Size Market Share by Region in 2024
Figure 41. APAC Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Figure 42. APAC Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Figure 43. China Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Japan Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45. South Korea Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 46. Southeast Asia Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 47. India Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Australia Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Europe Acinetobacter InfectionsTreatment Market Size Market Share by Country in 2024
Figure 50. Europe Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Figure 51. Europe Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Figure 52. Germany Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53.France Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 54. UK Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 55. Italy Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 56. Russia Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 57. Middle East & Africa Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Figure 58. Middle East & Africa Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Figure 59. Middle East & Africa Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Figure 60. Egypt Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 61. South Africa Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 62. Israel Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 63.Turkey Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 64. GCC Countries Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 65. Americas Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 66. APAC Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 67. Europe Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 68. Middle East & Africa Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 69. United States Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 70. Canada Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 71. Mexico Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 72. Brazil Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 73. China Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 74. Japan Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 75. Korea Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 76. Southeast Asia Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 77. India Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 78. Australia Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 79. Germany Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 80.France Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 81. UK Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 82. Italy Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 83. Russia Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 84. Egypt Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 85. South Africa Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 86. Israel Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 87.Turkey Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 88. Global Acinetobacter InfectionsTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 89. Global Acinetobacter InfectionsTreatment Market Size Market ShareForecast by Pipeline (2026-2031)
Figure 90. GCC Countries Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acinetobacter Infections Treatment Market Size (2020-2031)
2.1.2 Acinetobacter Infections Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Acinetobacter Infections Treatment by Country/Region (2020, 2024 & 2031)
2.2 Acinetobacter Infections Treatment Segment by Type
2.2.1 Sulbactam
2.2.2 Carbapenems
2.2.3 Aminoglycosides
2.2.4 Polymyxins
2.2.5 Tetracyclines
2.2.6 Others
2.3 Acinetobacter Infections Treatment Market Size by Type
2.3.1 Acinetobacter Infections Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Acinetobacter Infections Treatment Market Size Market Share by Type (2020-2025)
2.4 Acinetobacter Infections Treatment Segment by Pipeline
2.4.1 ETX2514
2.4.2 Nacubactam RG6080
2.4.3 Arenicin
2.4.4 VXD-001
2.4.5 Small Molecule Antibiotic
2.4.6 AR-401 mAB
2.4.7 LCB01-0371 (PO)
2.4.8 GN-4474
2.4.9 Antibacterial Antibody
2.5 Acinetobacter Infections Treatment Market Size by Pipeline
2.5.1 Acinetobacter Infections Treatment Market Size CAGR by Pipeline (2020 VS 2024 VS 2031)
2.5.2 Global Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2020-2025)
3 ACINETOBACTER INFECTIONS TREATMENT MARKET SIZE BY PLAYER
3.1 Acinetobacter Infections Treatment Market Size Market Share by Player
3.1.1 Global Acinetobacter Infections Treatment Revenue by Player (2020-2025)
3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Acinetobacter Infections Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACINETOBACTER INFECTIONS TREATMENT BY REGION
4.1 Acinetobacter Infections Treatment Market Size by Region (2020-2025)
4.2 Global Acinetobacter Infections Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acinetobacter Infections Treatment Market Size Growth (2020-2025)
4.4 APAC Acinetobacter Infections Treatment Market Size Growth (2020-2025)
4.5 Europe Acinetobacter Infections Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Acinetobacter Infections Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Acinetobacter Infections Treatment Market Size by Country (2020-2025)
5.2 Americas Acinetobacter Infections Treatment Market Size by Type (2020-2025)
5.3 Americas Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acinetobacter Infections Treatment Market Size by Region (2020-2025)
6.2 APAC Acinetobacter Infections Treatment Market Size by Type (2020-2025)
6.3 APAC Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acinetobacter Infections Treatment Market Size by Country (2020-2025)
7.2 Europe Acinetobacter Infections Treatment Market Size by Type (2020-2025)
7.3 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acinetobacter Infections Treatment by Region (2020-2025)
8.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACINETOBACTER INFECTIONS TREATMENT MARKET FORECAST
10.1 Global Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.1.1 Global Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.1.2 Americas Acinetobacter Infections Treatment Forecast
10.1.3 APAC Acinetobacter Infections Treatment Forecast
10.1.4 Europe Acinetobacter Infections Treatment Forecast
10.1.5 Middle East & Africa Acinetobacter Infections Treatment Forecast
10.2 Americas Acinetobacter Infections Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Acinetobacter Infections Treatment Forecast
10.2.2 Canada Market Acinetobacter Infections Treatment Forecast
10.2.3 Mexico Market Acinetobacter Infections Treatment Forecast
10.2.4 Brazil Market Acinetobacter Infections Treatment Forecast
10.3 APAC Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.3.1 China Acinetobacter Infections Treatment Market Forecast
10.3.2 Japan Market Acinetobacter Infections Treatment Forecast
10.3.3 Korea Market Acinetobacter Infections Treatment Forecast
10.3.4 Southeast Asia Market Acinetobacter Infections Treatment Forecast
10.3.5 India Market Acinetobacter Infections Treatment Forecast
10.3.6 Australia Market Acinetobacter Infections Treatment Forecast
10.4 Europe Acinetobacter Infections Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Acinetobacter Infections Treatment Forecast
10.4.2 France Market Acinetobacter Infections Treatment Forecast
10.4.3 UK Market Acinetobacter Infections Treatment Forecast
10.4.4 Italy Market Acinetobacter Infections Treatment Forecast
10.4.5 Russia Market Acinetobacter Infections Treatment Forecast
10.5 Middle East & Africa Acinetobacter Infections Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Acinetobacter Infections Treatment Forecast
10.5.2 South Africa Market Acinetobacter Infections Treatment Forecast
10.5.3 Israel Market Acinetobacter Infections Treatment Forecast
10.5.4 Turkey Market Acinetobacter Infections Treatment Forecast
10.6 Global Acinetobacter Infections Treatment Forecast by Type (2026-2031)
10.7 Global Acinetobacter Infections Treatment Forecast by Pipeline (2026-2031)
10.7.1 GCC Countries Market Acinetobacter Infections Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Entasis Therapeutics
11.1.1 Entasis Therapeutics Company Information
11.1.2 Entasis Therapeutics Acinetobacter Infections Treatment Product Offered
11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Entasis Therapeutics Main Business Overview
11.1.5 Entasis Therapeutics Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Acinetobacter Infections Treatment Product Offered
11.2.3 Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Adenium Biotech
11.3.1 Adenium Biotech Company Information
11.3.2 Adenium Biotech Acinetobacter Infections Treatment Product Offered
11.3.3 Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Adenium Biotech Main Business Overview
11.3.5 Adenium Biotech Latest Developments
11.4 Vaxdyn
11.4.1 Vaxdyn Company Information
11.4.2 Vaxdyn Acinetobacter Infections Treatment Product Offered
11.4.3 Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Vaxdyn Main Business Overview
11.4.5 Vaxdyn Latest Developments
11.5 Hsiri Therapeutics
11.5.1 Hsiri Therapeutics Company Information
11.5.2 Hsiri Therapeutics Acinetobacter Infections Treatment Product Offered
11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Hsiri Therapeutics Main Business Overview
11.5.5 Hsiri Therapeutics Latest Developments
11.6 Aridis Pharmaceuticals
11.6.1 Aridis Pharmaceuticals Company Information
11.6.2 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Offered
11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Aridis Pharmaceuticals Main Business Overview
11.6.5 Aridis Pharmaceuticals Latest Developments
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Company Information
11.7.2 LegoChem Biosciences Acinetobacter Infections Treatment Product Offered
11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 LegoChem Biosciences Main Business Overview
11.7.5 LegoChem Biosciences Latest Developments
11.8 Atterx Biotherapeutics
11.8.1 Atterx Biotherapeutics Company Information
11.8.2 Atterx Biotherapeutics Acinetobacter Infections Treatment Product Offered
11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Atterx Biotherapeutics Main Business Overview
11.8.5 Atterx Biotherapeutics Latest Developments
11.9 Achaogen
11.9.1 Achaogen Company Information
11.9.2 Achaogen Acinetobacter Infections Treatment Product Offered
11.9.3 Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Achaogen Main Business Overview
11.9.5 Achaogen Latest Developments
11.10 Peptilogics
11.10.1 Peptilogics Company Information
11.10.2 Peptilogics Acinetobacter Infections Treatment Product Offered
11.10.3 Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Peptilogics Main Business Overview
11.10.5 Peptilogics Latest Developments
11.11 Sealife PHARMA
11.11.1 Sealife PHARMA Company Information
11.11.2 Sealife PHARMA Acinetobacter Infections Treatment Product Offered
11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sealife PHARMA Main Business Overview
11.11.5 Sealife PHARMA Latest Developments
11.12 Shionogi
11.12.1 Shionogi Company Information
11.12.2 Shionogi Acinetobacter Infections Treatment Product Offered
11.12.3 Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Shionogi Main Business Overview
11.12.5 Shionogi Latest Developments
11.13 Techulon
11.13.1 Techulon Company Information
11.13.2 Techulon Acinetobacter Infections Treatment Product Offered
11.13.3 Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Techulon Main Business Overview
11.13.5 Techulon Latest Developments
11.14 Tetraphase Pharmaceuticals
11.14.1 Tetraphase Pharmaceuticals Company Information
11.14.2 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Offered
11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Tetraphase Pharmaceuticals Main Business Overview
11.14.5 Tetraphase Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Acinetobacter InfectionsTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Acinetobacter InfectionsTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sulbactam
Table 4. Major Players of Carbapenems
Table 5. Major Players of Aminoglycosides
Table 6. Major Players of Polymyxins
Table 7. Major Players ofTetracyclines
Table 8. Major Players of Others
Table 9. Acinetobacter InfectionsTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 11. Global Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Table 12. Acinetobacter InfectionsTreatment Market Size CAGR by Pipeline (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 14. Global Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Table 15. Global Acinetobacter InfectionsTreatment Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Acinetobacter InfectionsTreatment Revenue Market Share by Player (2020-2025)
Table 17. Acinetobacter InfectionsTreatment Key Players Head office and Products Offered
Table 18. Acinetobacter InfectionsTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Acinetobacter InfectionsTreatment Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Table 23. Global Acinetobacter InfectionsTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Acinetobacter InfectionsTreatment Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Acinetobacter InfectionsTreatment Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Acinetobacter InfectionsTreatment Market Size Market Share by Country (2020-2025)
Table 27. Americas Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 28. Americas Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Table 29. Americas Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 30. Americas Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Table 31. APAC Acinetobacter InfectionsTreatment Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Table 33. APAC Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 34. APAC Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 35. Europe Acinetobacter InfectionsTreatment Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Acinetobacter InfectionsTreatment Market Size Market Share by Country (2020-2025)
Table 37. Europe Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 38. Europe Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 39. Middle East & Africa Acinetobacter InfectionsTreatment Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Acinetobacter InfectionsTreatment Market Size byType (2020-2025) & ($ millions)
Table 41. Middle East & Africa Acinetobacter InfectionsTreatment Market Size by Pipeline (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Acinetobacter InfectionsTreatment
Table 43. Key Market Challenges & Risks of Acinetobacter InfectionsTreatment
Table 44. Key IndustryTrends of Acinetobacter InfectionsTreatment
Table 45. Global Acinetobacter InfectionsTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 46. Global Acinetobacter InfectionsTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 47. Global Acinetobacter InfectionsTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 48. Global Acinetobacter InfectionsTreatment Market SizeForecast by Pipeline (2026-2031) & ($ millions)
Table 49. EntasisTherapeutics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 50. EntasisTherapeutics Acinetobacter InfectionsTreatment Product Offered
Table 51. EntasisTherapeutics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. EntasisTherapeutics Main Business
Table 53. EntasisTherapeutics Latest Developments
Table 54. Roche Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 55. Roche Acinetobacter InfectionsTreatment Product Offered
Table 56. Roche Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Adenium Biotech Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 60. Adenium Biotech Acinetobacter InfectionsTreatment Product Offered
Table 61. Adenium Biotech Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Adenium Biotech Main Business
Table 63. Adenium Biotech Latest Developments
Table 64. Vaxdyn Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 65. Vaxdyn Acinetobacter InfectionsTreatment Product Offered
Table 66. Vaxdyn Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Vaxdyn Main Business
Table 68. Vaxdyn Latest Developments
Table 69. HsiriTherapeutics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 70. HsiriTherapeutics Acinetobacter InfectionsTreatment Product Offered
Table 71. HsiriTherapeutics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. HsiriTherapeutics Main Business
Table 73. HsiriTherapeutics Latest Developments
Table 74. Aridis Pharmaceuticals Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 75. Aridis Pharmaceuticals Acinetobacter InfectionsTreatment Product Offered
Table 76. Aridis Pharmaceuticals Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Aridis Pharmaceuticals Main Business
Table 78. Aridis Pharmaceuticals Latest Developments
Table 79. LegoChem Biosciences Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 80. LegoChem Biosciences Acinetobacter InfectionsTreatment Product Offered
Table 81. LegoChem Biosciences Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. LegoChem Biosciences Main Business
Table 83. LegoChem Biosciences Latest Developments
Table 84. Atterx Biotherapeutics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 85. Atterx Biotherapeutics Acinetobacter InfectionsTreatment Product Offered
Table 86. Atterx Biotherapeutics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Atterx Biotherapeutics Main Business
Table 88. Atterx Biotherapeutics Latest Developments
Table 89. Achaogen Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 90. Achaogen Acinetobacter InfectionsTreatment Product Offered
Table 91. Achaogen Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Achaogen Main Business
Table 93. Achaogen Latest Developments
Table 94. Peptilogics Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 95. Peptilogics Acinetobacter InfectionsTreatment Product Offered
Table 96. Peptilogics Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Peptilogics Main Business
Table 98. Peptilogics Latest Developments
Table 99. Sealife PHARMA Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 100. Sealife PHARMA Acinetobacter InfectionsTreatment Product Offered
Table 101. Sealife PHARMA Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Sealife PHARMA Main Business
Table 103. Sealife PHARMA Latest Developments
Table 104. Shionogi Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 105. Shionogi Acinetobacter InfectionsTreatment Product Offered
Table 106. Shionogi Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Shionogi Main Business
Table 108. Shionogi Latest Developments
Table 109.Techulon Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 110.Techulon Acinetobacter InfectionsTreatment Product Offered
Table 111.Techulon Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112.Techulon Main Business
Table 113.Techulon Latest Developments
Table 114.Tetraphase Pharmaceuticals Details, CompanyType, Acinetobacter InfectionsTreatment Area Served and Its Competitors
Table 115.Tetraphase Pharmaceuticals Acinetobacter InfectionsTreatment Product Offered
Table 116.Tetraphase Pharmaceuticals Acinetobacter InfectionsTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117.Tetraphase Pharmaceuticals Main Business
Table 118.Tetraphase Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Acinetobacter InfectionsTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acinetobacter InfectionsTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Acinetobacter InfectionsTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Acinetobacter InfectionsTreatment Sales Market Share by Country/Region (2024)
Figure 8. Acinetobacter InfectionsTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Acinetobacter InfectionsTreatment Market Size Market Share byType in 2024
Figure 10. Acinetobacter InfectionsTreatment in ETX2514
Figure 11. Global Acinetobacter InfectionsTreatment Market: ETX2514 (2020-2025) & ($ millions)
Figure 12. Acinetobacter InfectionsTreatment in Nacubactam RG6080
Figure 13. Global Acinetobacter InfectionsTreatment Market: Nacubactam RG6080 (2020-2025) & ($ millions)
Figure 14. Acinetobacter InfectionsTreatment in Arenicin
Figure 15. Global Acinetobacter InfectionsTreatment Market: Arenicin (2020-2025) & ($ millions)
Figure 16. Acinetobacter InfectionsTreatment in VXD-001
Figure 17. Global Acinetobacter InfectionsTreatment Market: VXD-001 (2020-2025) & ($ millions)
Figure 18. Acinetobacter InfectionsTreatment in Small Molecule Antibiotic
Figure 19. Global Acinetobacter InfectionsTreatment Market: Small Molecule Antibiotic (2020-2025) & ($ millions)
Figure 20. Acinetobacter InfectionsTreatment in AR-401 mAB
Figure 21. Global Acinetobacter InfectionsTreatment Market: AR-401 mAB (2020-2025) & ($ millions)
Figure 22. Acinetobacter InfectionsTreatment in LCB01-0371 (PO)
Figure 23. Global Acinetobacter InfectionsTreatment Market: LCB01-0371 (PO) (2020-2025) & ($ millions)
Figure 24. Acinetobacter InfectionsTreatment in GN-4474
Figure 25. Global Acinetobacter InfectionsTreatment Market: GN-4474 (2020-2025) & ($ millions)
Figure 26. Acinetobacter InfectionsTreatment in Antibacterial Antibody
Figure 27. Global Acinetobacter InfectionsTreatment Market: Antibacterial Antibody (2020-2025) & ($ millions)
Figure 28. Global Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline in 2024
Figure 29. Global Acinetobacter InfectionsTreatment Revenue Market Share by Player in 2024
Figure 30. Global Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Figure 31. Americas Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 32. APAC Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 33. Europe Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 34. Middle East & Africa Acinetobacter InfectionsTreatment Market Size 2020-2025 ($ millions)
Figure 35. Americas Acinetobacter InfectionsTreatment Value Market Share by Country in 2024
Figure 36. United States Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Canada Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Mexico Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 39. Brazil Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 40. APAC Acinetobacter InfectionsTreatment Market Size Market Share by Region in 2024
Figure 41. APAC Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Figure 42. APAC Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Figure 43. China Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Japan Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45. South Korea Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 46. Southeast Asia Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 47. India Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Australia Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Europe Acinetobacter InfectionsTreatment Market Size Market Share by Country in 2024
Figure 50. Europe Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Figure 51. Europe Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Figure 52. Germany Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53.France Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 54. UK Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 55. Italy Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 56. Russia Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 57. Middle East & Africa Acinetobacter InfectionsTreatment Market Size Market Share by Region (2020-2025)
Figure 58. Middle East & Africa Acinetobacter InfectionsTreatment Market Size Market Share byType (2020-2025)
Figure 59. Middle East & Africa Acinetobacter InfectionsTreatment Market Size Market Share by Pipeline (2020-2025)
Figure 60. Egypt Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 61. South Africa Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 62. Israel Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 63.Turkey Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 64. GCC Countries Acinetobacter InfectionsTreatment Market Size Growth 2020-2025 ($ millions)
Figure 65. Americas Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 66. APAC Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 67. Europe Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 68. Middle East & Africa Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 69. United States Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 70. Canada Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 71. Mexico Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 72. Brazil Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 73. China Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 74. Japan Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 75. Korea Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 76. Southeast Asia Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 77. India Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 78. Australia Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 79. Germany Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 80.France Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 81. UK Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 82. Italy Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 83. Russia Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 84. Egypt Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 85. South Africa Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 86. Israel Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 87.Turkey Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
Figure 88. Global Acinetobacter InfectionsTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 89. Global Acinetobacter InfectionsTreatment Market Size Market ShareForecast by Pipeline (2026-2031)
Figure 90. GCC Countries Acinetobacter InfectionsTreatment Market Size 2026-2031 ($ millions)
More Publications
Global Relative Analgesia Machine Market Growth 2023-2029
US$ 3,660.00
March 2023
97 pages
Global Intramedullary Nail Market Growth 2026-2032
US$ 3,660.00
May 2026
115 pages
Global Erythrocyte Sedimentation Rate Analyzer Market Growth 2025-2031
US$ 3,660.00
April 2025
160 pages
Global CRO in Clinical Trials Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
April 2025
106 pages
